Cargando…

Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines

Detalles Bibliográficos
Autor principal:	Teo, Shyh Poh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Geriatrics Society 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497946/ https://www.ncbi.nlm.nih.gov/pubmed/34333959 http://dx.doi.org/10.4235/agmr.21.0057

Ejemplares similares

Axillary Adenopathy in Patients with Recent Covid-19 Vaccination: A New Diagnostic Dilemma
por: Ashoor, Arwa, et al.
Publicado: (2021)

Re: Unilateral axillary adenopathy in the setting of COVID-19 vaccine, Clinical Imaging, January 2021
por: Finnegan, John, et al.
Publicado: (2021)

Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination
por: Robinson, Kristin A., et al.
Publicado: (2021)

Unilateral axillary Adenopathy in the setting of COVID-19 vaccine
por: Mehta, Nishi, et al.
Publicado: (2021)

COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma
por: Prieto, Peter A, et al.
Publicado: (2021)

Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up
por: Mehta, Nishi, et al.
Publicado: (2021)

Breast Cancer Screening and Axillary Adenopathy in the Era of COVID-19 Vaccination
por: Wolfson, Stacey, et al.
Publicado: (2022)

Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram
por: Wolfson, Stacey, et al.
Publicado: (2022)

Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination
por: Horvat, Joao V., et al.
Publicado: (2022)

Axillary adenopathy after COVID-19 vaccine in patients undergoing breast ultrasound
por: Giorgis, Sara De, et al.
Publicado: (2021)

Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram
por: Wolfson, Stacey, et al.
Publicado: (2022)

Invited Commentary: Evolving Management of COVID-19 Vaccine–related Axillary Adenopathy
por: Weinstein, Susan
Publicado: (2022)

A Call to Enhance Active and Transparent Pharmacovigilance for COVID-19 Vaccines
por: Kunene, Khontile Nobuhle, et al.
Publicado: (2023)

Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation
por: Igual-Rouilleault, Alba Cristina, et al.
Publicado: (2021)

Axillary adenopathy following COVID-19 vaccination: A single institution case series
por: Duke, Heather, et al.
Publicado: (2021)

Frequency and Outcomes of Ipsilateral Axillary Lymphadenopathy After COVID-19 Vaccination
por: Zhou, Wenhui, et al.
Publicado: (2022)

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma
por: Ashoor, Arwa, et al.
Publicado: (2022)

Interpretation of Antigen-detection Rapid Diagnostic Tests (Ag-RDTs) Should Take into Account the Pre-test Probability of COVID-19 Infection
por: Teo, Shyh Poh
Publicado: (2022)

Adenopathy Following COVID-19 Vaccination
por: Washington, Tina, et al.
Publicado: (2021)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Axillary adenopathy detected on breast MRI following COVID-19 vaccination: outcomes and follow-up recommendations
por: Nguyen, Derek L., et al.
Publicado: (2023)

Temporal metabolic response and mRNA COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis
por: Faissner, Simon, et al.
Publicado: (2021)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Painless thyroiditis following mRNA vaccination for COVID-19
por: Nakaizumi, Nobuhiko, et al.
Publicado: (2022)

Effectiveness of mRNA Covid-19 vaccine in healthcare workers
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

COVID-19 mRNA vaccination in patients with previous myocarditis
por: Pieroni, Maurizio, et al.
Publicado: (2022)

Panuveitis following mRNA-based COVID-19 vaccine
por: Bouayad, A., et al.
Publicado: (2023)

Axillary Lymphadenopathy After mRNA COVID-19 Vaccination
por: Ahn, Richard W., et al.
Publicado: (2021)

Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines
por: Brown, A., et al.
Publicado: (2021)

Ipsilateral Lymphadenopathy, COVID-19 Vaccination and Breast Cancer
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Axillary Adenopathy Secondary to SARS-CoV-2 Vaccination: a Case Report
por: Koff, Alan, et al.
Publicado: (2022)

Membranous nephropathy following anti–COVID-19 mRNA vaccination
por: Gueguen, Lorraine, et al.
Publicado: (2021)

HeartWare Thrombosis After mRNA COVID-19 Vaccination
por: Schettle, Sarah, et al.
Publicado: (2022)

Livedoid skin reaction and mRNA Covid-19 vaccine: correspondence
por: Mungunpuntipantip, Rujittika, et al.
Publicado: (2023)

Ultrasound Features to Differentiate COVID-19 Vaccine-Induced Benign Adenopathy from Breast Cancer Related Malignant Adenopathy
por: HL, Chung, et al.
Publicado: (2022)

Adult-onset Still's disease following mRNA COVID-19 vaccination
por: Sharabi, Amir, et al.
Publicado: (2021)

mRNA COVID-19 Vaccine–Related Anaphylactoid Reaction and Coronary Thrombosis
por: Hinton, Jonathan, et al.
Publicado: (2021)

Perniosis-like lesions after vaccination with mRNA against COVID-19()
por: Pérez-López, Israel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uaqvmdhpol67iag40p40m68jsb